The deal is valid for SourceOne offerings like the botancials Cholesstrinol HPe, GymnePURE, and LeptiPURE.
“[Gee Lawson’s] expertise representing branded ingredient suppliers is peerless and their reputation for having an uncompromising commitment to science, innovation, quality, and integrity is why we chose them,” said SourceOne CEO and founder Jesse Lopez.
Gee Lawson managing director Jonathan Shorts said the deal was “strategically important to our long-term success meeting customer needs for differentiated products.”
The firms are employing a Swiss processing technology called VESIsorb which trials have shown can boost nutrient bioavailability via a “self-assembling colloidal droplet system.”
Gee Lawson's portfolio includes organic and non-organic botanicals, marine-sourced nutrients and branded ingredients.